OTC Medicines

Browse OTC Medicines Content

Herein CHPA provides comments on Citizen Petition #FDA-2016-P-43881, which requests an amendment of the marketing status for loperamide (Imodium) from nonprescription to prescription.

Sep 5, 2017

CHPA comments on what should be included in a sectoral annex on pharmaceuticals in the TBT chapter of NAFTA.

Sep 5, 2017

Letter regarding modernization of the USP compendia for OTC medicines. CHPA supports improving the compendial test methods and establishing product standards for safety.

Jul 27, 2017

Herein, CHPA provides comments on Citizen Petition FDA-2017-P-27331 which requests the addition of a warning to labeling for all OTC drug products labeled to relieve or prevent heartburn associated with reflux disease, acid indigestion, and sour stomach noting that these products do not eliminate the risk of esophageal cancer.

Jul 19, 2017

CHPA congratulates the House of Representatives on the passage of the Food and Drug Administration Reauthorization Act of 2017.

Jul 12, 2017

To combat teen abuse of over-the-counter (OTC) medicines containing the cough suppressant dextromethorphan (DXM), Oregon Governor Kate Brown today signed legislation prohibiting the sale of DXM-containing products to minors.

Jun 15, 2017

This week, Nevada Governor Brian Sandoval signed legislation prohibiting the sale of over-the-counter (OTC) medicines containing the cough suppressant dextromethorphan (DXM) to minors.

Jun 1, 2017

CHPA appreciates the opportunity to provide our comments to the EPA regarding the Executive order, "Enforcing the Regulatory Reform Agenda".

May 15, 2017

A newly published article in the medical journal Pediatrics concludes that over-the-counter (OTC) cough and cold medicines for children are safe when used and stored as directed.

May 4, 2017

New research from CHPA and Nielsen indicates that more Americans are suffering from seasonal allergies and are choosing nonprescription, OTC, treatments rather than prescription medications.

Mar 16, 2017

Filter Results